THRD THIRD HARMONIC BIO INC revenue, earnings and financials
For the quarter ended March 31, 2025, THIRD HARMONIC BIO INC reported revenue of n/a, net income of −$15.8M and diluted EPS of $0.35; for the fiscal year ended December 2024 revenue was n/a.
THRD annual revenue and earnings
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$58.9M, net income −$45.5M (margin n/a), EPS $1.09
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$44.0M, net income −$30.8M (margin n/a), EPS $0.78
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$37.7M, net income −$35.2M (margin n/a), EPS $2.45
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$19.0M, net income −$29.6M (margin n/a), EPS −$7.32
THRD quarterly revenue and earnings
- Quarter ended Mar 31, 2025: revenue n/a, net income −$15.8M, EPS $0.35
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$13.1M, EPS $0.30
- Quarter ended Sep 30, 2024: revenue n/a, net income −$13.8M, EPS $0.33
- Quarter ended Jun 30, 2024: revenue n/a, net income −$10.7M, EPS $0.26
- Quarter ended Mar 31, 2024: revenue n/a, net income −$7.86M, EPS $0.20
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$6.84M, EPS $0.17
- Quarter ended Sep 30, 2023: revenue n/a, net income −$7.34M, EPS $0.19
- Quarter ended Jun 30, 2023: revenue n/a, net income −$7.56M, EPS $0.19
- Quarter ended Mar 31, 2023: revenue n/a, net income −$9.09M, EPS $0.23
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$11.5M, EPS −$2.03
- Quarter ended Sep 30, 2022: revenue n/a, net income −$8.21M, EPS $0.90
- Quarter ended Jun 30, 2022: revenue n/a, net income −$7.68M, EPS $1.76
- Quarter ended Mar 31, 2022: revenue n/a, net income −$7.78M, EPS $1.82
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$15.8M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income −$7.38M, EPS $1.80
- Quarter ended Jun 30, 2021: revenue n/a, net income −$4.20M, EPS n/a
- Quarter ended Mar 31, 2021: revenue n/a, net income −$2.25M, EPS n/a
THRD cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow −$34.5M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$20.4M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$34.9M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$15.7M, share buybacks n/a
THRD balance sheet
- Mar 31, 2025: cash $272M, total assets $280M, total liabilities $7.22M, shareholders' equity $273M
- Dec 31, 2024: cash $285M, total assets $295M, total liabilities $9.46M, shareholders' equity $285M
- Sep 30, 2024: cash $296M, total assets $304M, total liabilities $9.64M, shareholders' equity $295M
- Jun 30, 2024: cash $255M, total assets $266M, total liabilities $9.14M, shareholders' equity $257M
- Mar 31, 2024: cash $263M, total assets $271M, total liabilities $7.02M, shareholders' equity $264M
- Dec 31, 2023: cash $269M, total assets $278M, total liabilities $8.63M, shareholders' equity $269M
- Sep 30, 2023: cash $274M, total assets $282M, total liabilities $9.29M, shareholders' equity $273M
- Jun 30, 2023: cash $278M, total assets $286M, total liabilities $7.81M, shareholders' equity $278M
Is THRD profitable?
No. THIRD HARMONIC BIO INC lost $53.4M over the last four quarters.
What is THRD's EPS?
Diluted earnings per share over the last four quarters were $1.24; $0.35 in the latest quarter.